abiraterone FDA approval date

The FDA approved abiraterone (Zytiga(R)) on 28 Apr 2011.

FDA approval date
28 Apr 2011

Drug identity checked against registry records

Also recorded as Zytiga(R); abiraterone acetate

Included trials

TrialSponsorPhaseStatusPrimary completion
Combo of Cabozantinib With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic CRPCNCT01995058ExelixisPhase 2Terminated2014-11Actual

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2011-04-28DayabirateroneFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA202379", "applicant_as_listed_by_fda": "JANSSEN BIOTECH", "brand_names": ["ZYTIGA"], "active_ingredients": ["ABIRATERONE ACETATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20110428", "matched_on": "registry alias equals FDA brand name and drug name is its active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026